Atlas FDA

Predicate Research Report · generated 2026-08-23 · Print / save as PDF · Save to account

Hyland Therapeutic Div., Travenol Laboratories · Predicate Candidate Screening

44 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

44 daysmedian FDA review time
105 days90th percentile
44clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K820835ALUMINA SILICA-ACTIVATED PARTIAL THROMHyland Therapeutic Div., Travenol Laboratories1982-04-26310
K820192HAEMOPHILUS INFLUENZAE TYPE B ANTISERUMHyland Therapeutic Div., Travenol Laboratories1982-03-11450
K812220NEPHELOMETRIC SOLID TURBIDITY STANDARDHyland Therapeutic Div., Travenol Laboratories1981-08-18120
K810078Q-PAK THERAPEUTIC DRUG MONIT. CONTROL SHyland Therapeutic Div., Travenol Laboratories1981-02-02200
K810077OMEGA THERAPEUTIC DRUG MONIT. CONTROL S.Hyland Therapeutic Div., Travenol Laboratories1981-01-28150
K802610ALERT A,HDL-APOLIPOROTEIN A, TEST KITHyland Therapeutic Div., Travenol Laboratories1981-01-05760
K791113LOW IONIC STRENGTH SOLUTION (LISS)Hyland Therapeutic Div., Travenol Laboratories1979-06-28130
K790249TEST CELLSHyland Therapeutic Div., Travenol Laboratories1979-05-16970
K781225GLOBULIN TEST, HUMAN THYROXINE BINDINGHyland Therapeutic Div., Travenol Laboratories1978-08-31440
K780962AUTOMATED ENZYMEHyland Therapeutic Div., Travenol Laboratories1978-07-27450
K780785DILUTOR TRANSPORTERHyland Therapeutic Div., Travenol Laboratories1978-06-14330
K780753LAS-R HUMAN IGE TESTHyland Therapeutic Div., Travenol Laboratories1978-06-06290
K780729LAS-R HUMAN COMPLEMENT CLQ TESTHyland Therapeutic Div., Travenol Laboratories1978-05-18160
K780203THROMBOPLASTIN DRIEDHyland Therapeutic Div., Travenol Laboratories1978-03-27480
K780335LAS-R HUMAN C1 ESTERASE INHIBITOR TESTHyland Therapeutic Div., Travenol Laboratories1978-03-22220
K780204CHEMISTRY CONTROL & REFERENCE SERUMSHyland Therapeutic Div., Travenol Laboratories1978-03-03240
K772327LAS-R HUMAN IGD TESTHyland Therapeutic Div., Travenol Laboratories1978-02-28690
K772328LAS-R HUMAN ANTITHROMBIN III TESTHyland Therapeutic Div., Travenol Laboratories1978-02-03440
K772329LAS-R HUMAN PREALBUMIN TESTHyland Therapeutic Div., Travenol Laboratories1978-02-03440
K772084LAS-R HUMAN C3 PROACTIVATOR TESTHyland Therapeutic Div., Travenol Laboratories1978-01-24810
K772085LAS-R HUMAN PLASMINOGEN TESTHyland Therapeutic Div., Travenol Laboratories1978-01-24810
K771445HERPES I.D. TM TESTHyland Therapeutic Div., Travenol Laboratories1977-12-141350
K771795LAS-R CERULOPLASMIN TESTHyland Therapeutic Div., Travenol Laboratories1977-11-14520
K771700TMA BICARBONATE/GLYCEROL DILUENTHyland Therapeutic Div., Travenol Laboratories1977-11-11650
K771879GLYCOPROTEIN TEST, LAS-R HUMAN 1-ACIDHyland Therapeutic Div., Travenol Laboratories1977-10-19150
K771912LAS-R BETA LIPOPROTEIN TESTHyland Therapeutic Div., Travenol Laboratories1977-10-1980
K771780LAS-R TMHyland Therapeutic Div., Travenol Laboratories1977-10-04110
K771535LAS-R HUMAN CRP TESTHyland Therapeutic Div., Travenol Laboratories1977-09-02230
K771552LAS-R RHEUMATOID FACTOR TESTHyland Therapeutic Div., Travenol Laboratories1977-08-30180
K771446TRANSPORTEO MODULEHyland Therapeutic Div., Travenol Laboratories1977-08-1090
K771226LAS-R TEST PROGRAMHyland Therapeutic Div., Travenol Laboratories1977-07-21200
K771044TMA BICARBONATE DILUENTHyland Therapeutic Div., Travenol Laboratories1977-07-15350
K770547LAS-R TM HUMAN COMPLEMENT C4 TESTHyland Therapeutic Div., Travenol Laboratories1977-05-03430
K770010Q-PAK CHEMISTRY RADIORECEPTOR CONTROL AHyland Therapeutic Div., Travenol Laboratories1977-04-181050
K770011Q-PAK CHEMISTRY RADIORECEPTOR CONTROL BHyland Therapeutic Div., Travenol Laboratories1977-04-181050
K770012Q-PAK CHEMISTRY RADIORECEPTOR CONTROL CHyland Therapeutic Div., Travenol Laboratories1977-04-181050
K770548IMMUNOPLATE III RADIO IMMUNODIFFUSIONHyland Therapeutic Div., Travenol Laboratories1977-04-15250
K761008LYMPHOCYTE TYPING, NEGATIVE CONTROLHyland Therapeutic Div., Travenol Laboratories1977-04-061550
K761009LYMPHOCYTE TYPING, POSITIVE CONTROLHyland Therapeutic Div., Travenol Laboratories1977-04-061550
K760918HEPARIN CONTROL PLASMAHyland Therapeutic Div., Travenol Laboratories1977-01-10740
K760917LAS-R HUMAN HAPTOGLOBIN TESTHyland Therapeutic Div., Travenol Laboratories1976-12-30630
K760916LAS-R HUMAN ALPHA, ANTITRYPSIN TESTHyland Therapeutic Div., Travenol Laboratories1976-11-16190
K760818TRIS BICARBONATE DILUENTHyland Therapeutic Div., Travenol Laboratories1976-11-05240
K760499REAGENT, PARTIAL THROMBOPLASTINHyland Therapeutic Div., Travenol Laboratories1976-10-29670

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda